An iTRAQ approach to quantitative proteome analysis of cerebrospinal fluid from patients with tuberculous meningitis

BioScience Trends

Volumn 7, Issue 4, 2013, Pages 186-192

  Ou, Qiang ^a,b   Liu, Xiaohui ^c   Cheng, Xunjia ^a,c  

^a FUDAN UNIVERSITY   (China)

^b TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Biomarker; iTRAQ; LC MS; Tuberculous meningitis (TBM)

Indexed keywords

ANIMAL; ARTICLE; BODY WEIGHT; C57BL MOUSE; CELL CULTURE; CEREBROSPINAL FLUID; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; METABOLISM; METHODOLOGY; MOUSE; ORGAN SIZE; PHYSIOLOGY; PROTEOMICS; SPLEEN; TUBERCULOUS MENINGITIS;

ANIMALS; BODY WEIGHT; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; ORGAN SIZE; PROTEOMICS; SPLEEN; TUBERCULOSIS, MENINGEAL;

EID: 84886291877     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2013.v7.4.186     Document Type: Article

References (33)

1. Sheu JJ, Yuan RY, Yang CC. Predictors for outcome and treatment delay in patients with tuberculous meningitis. Am J Med Sci. 2009; 338:134-139.
2. Chugh A, Husain M, Gupta RK, Ojha BK, Chandra A, Rastogi M. Surgical outcome of tuberculous meningitis hydrocephalus treated by endoscopic third ventriculostomy: Prognostic factors and postoperative neuroimaging for functional assessment of ventriculostomy. J Neurosurg Pediatr. 2009; 3:371-377.
3. Pan S, Zhu D, Quinn JF, Peskind ER, Montine TJ, Lin B, Goodlett DR, Taylor G, Eng J, Zhang J. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics. 2007; 7:469-473.
4. Bai S, Liu S, Guo X, Qin Z, Wang B, Li X, Qin Y, Liu YH. Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients. Mol Vis. 2009; 15:1638-1648.
5. Blennow K. CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment. Expert Rev Mol Diagn. 2005; 5:661-672.
6. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L. Identification of potential CSF biomarkers in ALS. Neurology. 2006; 66:1218-1222.
7. Kumar GS, Venugopal AK, Mahadevan A, et al. Quantitative proteomics for identifying biomarkers for tuberculous meningitis. Clin Proteomics. 2012; 9:12.
8. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 2000; 21:1164-1177.
9. Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004; 3:1154-1169.
10. Ogata Y, Charlesworth MC, Higgins L, Keegan BM, Vernino S, Muddiman DC. Differential protein expression in male and female human lumbar cerebrospinal fluid using iTRAQ reagents after abundant protein depletion. Proteomics. 2007; 7:3726-3734.
11. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-254.
12. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, Hunter CL, Nuwaysir LM, Schaeffer DA. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics. 2007; 6:1638-1655.
13. Latterich M, Abramovitz M, Leyland-Jones B. Proteomics: New technologies and clinical applications. Eur J Cancer.2008; 44:2737-2741.
14. Aggarwal K, Choe LH, Lee KH. Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomics. 2006; 5:112-120.
15. Seeliger S, Vogl T, Engels IH, Schröder JM, Sorg C, Sunderkötter C, Roth J. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am J Pathol. 2003; 163:947-956.
16. Mueller A, O'Rourke J, Grimm J, Guillemin K, Dixon MF, Lee A, Falkow S. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A. 2003; 100:1292- 1297.
17. Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/ S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009; 86:557- 566.
18. Vogt L, Schrimpf SP, Meskenaite V, Frischknecht R, Kinter J, Leone DP, Ziegler U, Sonderegger P. Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain. Mol Cell Neurosci. 2001; 17:151-166.
19. Rutledge AC, Su Q, Adeli K. Apolipoprotein B100 biogenesis: A complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly. Biochem Cell Biol. 2010; 88:251-267.
20. Sniderman AD, Holme I, Aastveit A, Furberg C, Walldius G, Jungner I. Relation of age, the apolipoprotein B/ apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease. Am J Cardiol. 2007; 100:217-221.
21. Wong WM, Gerry AB, Putt W, Roberts JL, Weinberg RB, Humphries SE, Leake DS, Talmud PJ. Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis. 2007; 192:266-274.
22. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006; 367:1262-1270.
23. Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain research. 1997; 751:307-314.
24. Hafezi-Moghadam A, Thomas KL, Wagner DD. ApoE deficiency leads to a progressive age-dependent bloodbrain barrier leakage. Am J Physiol Cell Physiol. 2007; 292:C1256-1262.
25. Tzourio C, Arima H, Harrap S, Anderson C, Godin O, Woodward M, Neal B, Bousser MG, Chalmers J, Cambien F, MacMahon S. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology. 2008; 70:1322-1328.
26. Huang X, Chen P, Kaufer DI, Tröster AI, Poole C. Apolipoprotein E and dementia in Parkinson disease: A meta-analysis. Arch Neurol. 2006; 63:189-193.
27. Kim J , Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009; 63:287-303.
28. Padmanabhan J, Levy M, Dickson DW, Potter H. Alpha1- antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain. 2006; 129:3020-3034.
29. Baker C, Nielsen HM, Minthon L, Wright HT, Chappell S, Okyere J, May S, Morgan K, Kalsheker N, Janciauskiene SM. Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression. Neurobiol Aging. 2007; 28:51-61.
30. Yamshchikov AV, Kurbatova EV, Kumari M, Blumberg HM, Ziegler TR, Ray SM, Tangpricha V. Vitamin D status and antimicrobial peptide cathelicidin (LL- 37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr. 2010; 92:603-611.
31. Méndez-Samperio P. The human cathelicidin hCAP18/ LL-37: A multifunctional peptide involved in mycobacterial infections. Peptides. 2010; 31:1791-1798.
32. Li W, Tao R, Zhang X, Ju G, Shi J, Liu S, Wang Z, Jin S, Guo Y, Wei J. A family-based study of genetic association of the PTGDS gene with schizophrenia in a Chinese population. Psychiatr Genet. 2008; 18:99.
33. arrington MG, Fonteh AN, Biringer RG, R Hühmer AF, Cowan RP. Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology. Dis Markers. 2006; 22:73-81.